Skip to content
DAT Supply Log in
Botanicals · Gummies

Fenugreek Extract

Fenugreek extract is a botanical ingredient derived from Trigonella foenum-graecum seeds, commonly used in men's health and vitality gummies. It has no authorised EU health claims under Reg. 432/2012 (on-hold botanical). Brands typically position it around testosterone support, libido, and sports recovery, often co-formulated with Zinc or Tribulus for claim coverage.

  • testosterone-support
  • libido
  • men-health
Build a formula with this ingredient
Fenugreek Extract

At a glance

Definition
Fenugreek extract is a botanical ingredient derived from Trigonella foenum-graecum seeds, commonly used in men's health and vitality gummies. It has no authorised EU health claims under Reg. 432/2012 (on-hold botanical). Brands typically position it around testosterone support, libido, and sports recovery, often co-formulated with Zinc or Tribulus for claim coverage.
Common positionings
  • testosterone support
  • libido enhancement
  • men's vitality, sports recovery, metabolic health, healthy ageing
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Fenugreek extract is a botanical ingredient derived from the seeds of Trigonella foenum-graecum, a plant native to the Mediterranean and Western Asia. It has a long history of use in traditional medicine systems, particularly in Ayurveda and traditional Chinese medicine, where it has been used to support vitality, libido, and metabolic health. In modern nutraceutical manufacturing, fenugreek extract is valued for its low cost, pleasant maple-like aroma, and compatibility with gummy formats.

Brands use fenugreek extract in private-label gummies primarily for men's health and sports recovery positioning. It is one of the most familiar and commercially understood botanical actives across EU and US markets for testosterone and libido support. Because fenugreek is an on-hold botanical under EU Regulation 432/2012, no authorised health claims are available. Brands typically co-formulate with Zinc (authorised for normal testosterone levels) or Vitamin B6 (authorised for hormone regulation) to support claim coverage.

Origin and history

Fenugreek has been cultivated for thousands of years across the Mediterranean, North Africa, and South Asia. Its seeds have been used both as a culinary spice and as a traditional remedy for digestive health, lactation support, and male vitality. The name "fenugreek" derives from Latin *faenum-graecum*, meaning "Greek hay", reflecting its historical use as fodder.

Industrial production of fenugreek extract involves cleaning and grinding the seeds, followed by solvent or water extraction to concentrate the active compounds, primarily steroidal saponins (such as protodioscin), alkaloids, and flavonoids. The extract is then spray-dried or freeze-dried to produce a powder suitable for encapsulation or gummy manufacturing. Standardisation to a specific saponin content (e.g. 50%) is common for consistency across batches.

Scientific overview

Fenugreek's primary bioactive compounds are steroidal saponins, particularly protodioscin, which are thought to support testosterone metabolism by inhibiting enzymes that convert testosterone to dihydrotestosterone (DHT) and oestrogen. This mechanism is the basis for its traditional use in male vitality and libido support. Fenugreek also contains 4-hydroxyisoleucine, an amino acid that may influence glucose and insulin metabolism, contributing to its traditional use in metabolic health.

Bioavailability of fenugreek saponins is moderate, with oral administration showing measurable plasma levels. Standardised extracts with higher saponin content (e.g. 50%) are preferred for consistent dosing. The whole seed powder is less concentrated and requires higher doses. Fenugreek is heat-stable and soluble in gummy formulations, making it suitable for gummy manufacturing without significant degradation during processing.

Manufacturing watchpoints include the characteristic maple-like aroma, which can be pleasant in gummies but may require masking in other formats. Fenugreek can cause a harmless maple syrup-like scent in urine, which is a known consumer observation but not a safety concern. Cost-per-mg is low, making fenugreek an economical active for high-dose gummy formulations.

Why brands use Fenugreek Extract

Fenugreek extract is a strong candidate for men's health and sports recovery gummy ranges. Its low cost, pleasant taste, and heat stability make it formulation-friendly. Brands can position it around testosterone support, libido enhancement, and post-workout recovery, often in combination with Zinc, Tribulus, or Maca. The maple-like aroma can be a distinctive selling point in gummy formats.

From a manufacturing perspective, fenugreek extract is easy to work with. It is heat-stable, soluble in gummy bases, and does not require special handling. The low cost allows for high-dose formulations (300–2000 mg per serving) without significant impact on product cost. DAT confirms final dosing and formulation parameters per project.

For pack copy, brands must remember that fenugreek has no authorised EU health claims under Reg. 432/2012. Claim coverage should come from co-formulated nutrients such as Zinc (for normal testosterone levels) or Vitamin B6 (for hormone regulation). No disease claims are permitted. DAT reviews claim strategy per project to ensure compliance with EU and UK regulations.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Low

Forms available

  • Standardised extract (e.g. 50% fenugreek saponins), whole seed powder, hydro-alcoholic extract

Dosage reference

Brand positioning typically ranges from 300 mg to 2000 mg per serving. No EU NRV established. DAT confirms final dosage per project based on target market and claim strategy.

Taste & sensory

Maple-like aroma. Pleasant in gummy.

Manufacturing notes

Gummy-optimised dosing and format considerations.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

EU-authorised health claims

EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.

Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.

Fenugreek is a botanical on the EU on-hold list. No authorised health claims under Reg. 432/2012. Brands should position around traditional use or co-formulate with claim-authorised nutrients. DAT reviews claim strategy per project.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Wilborn C, Taylor L, Poole C, et al.·Journal of the International Society of Sports Nutrition·2010

  2. Rao A, Steels E, Inder WJ, et al.·Phytotherapy Research·2016

  3. Neelakantan N, Narayanan M, de Souza RJ, et al.·Nutrition Reviews·2014

  4. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)·EFSA Journal·2017

  5. Acharya SN, Thomas JE, Basu SK·Journal of Ethnopharmacology·2008

Catalogue match

Product concepts featuring Fenugreek Extract

Private-label product concepts where Fenugreek Extract appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Pairs with Tribulus (testosterone), Zinc (testosterone), Maca (libido)

Care when combining with

Maple syrup-scented urine (harmless). Avoid in pregnancy. Diabetics monitor blood sugar.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Fenugreek Extract on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Fenugreek Extract.

Project handoff

Develop a formula featuring Fenugreek Extract

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.